IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 88.237
AS - Asia 14.995
EU - Europa 10.829
SA - Sud America 2.072
AF - Africa 216
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 34
Totale 116.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 87.752
SG - Singapore 8.051
CN - Cina 2.642
IT - Italia 2.610
RU - Federazione Russa 1.772
BR - Brasile 1.723
HK - Hong Kong 1.296
VN - Vietnam 1.150
IE - Irlanda 1.147
DE - Germania 1.085
FR - Francia 863
UA - Ucraina 819
GB - Regno Unito 639
SE - Svezia 456
JP - Giappone 430
FI - Finlandia 408
CA - Canada 314
IN - India 302
PL - Polonia 287
KR - Corea 250
NL - Olanda 238
AR - Argentina 136
ID - Indonesia 125
MX - Messico 105
BD - Bangladesh 104
ES - Italia 102
AT - Austria 87
TR - Turchia 83
IQ - Iraq 78
UZ - Uzbekistan 77
ZA - Sudafrica 73
EC - Ecuador 61
BE - Belgio 59
AU - Australia 54
MY - Malesia 45
CO - Colombia 43
PH - Filippine 41
LT - Lituania 37
PK - Pakistan 37
AE - Emirati Arabi Uniti 36
EG - Egitto 36
RO - Romania 33
SA - Arabia Saudita 33
IL - Israele 29
MA - Marocco 29
KG - Kirghizistan 28
CH - Svizzera 26
CL - Cile 26
EU - Europa 25
JO - Giordania 24
PY - Paraguay 23
CZ - Repubblica Ceca 22
IR - Iran 21
PE - Perù 21
VE - Venezuela 21
PT - Portogallo 20
TH - Thailandia 20
TN - Tunisia 19
AZ - Azerbaigian 16
DZ - Algeria 16
SK - Slovacchia (Repubblica Slovacca) 16
HU - Ungheria 15
UY - Uruguay 15
GR - Grecia 13
RS - Serbia 13
DK - Danimarca 12
DO - Repubblica Dominicana 12
JM - Giamaica 11
KE - Kenya 11
HR - Croazia 10
TW - Taiwan 10
LB - Libano 9
NP - Nepal 9
PA - Panama 9
KZ - Kazakistan 8
ET - Etiopia 7
OM - Oman 7
TT - Trinidad e Tobago 7
AL - Albania 6
CR - Costa Rica 6
GE - Georgia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GH - Ghana 5
HN - Honduras 5
LV - Lettonia 5
NO - Norvegia 5
SN - Senegal 5
AO - Angola 4
BG - Bulgaria 4
BH - Bahrain 4
LK - Sri Lanka 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CY - Cipro 3
LU - Lussemburgo 3
MD - Moldavia 3
MN - Mongolia 3
Totale 116.397
Salva come PNG Salva come JPEG
Città #
Wilmington 23.088
Houston 21.915
Woodbridge 17.401
Singapore 3.460
Fairfield 3.254
Ashburn 2.255
Chandler 1.871
San Jose 1.646
Seattle 1.349
Ann Arbor 1.301
Hong Kong 1.268
Cambridge 1.199
Dublin 1.046
Beijing 975
Medford 736
Jacksonville 638
Rome 620
Dearborn 569
The Dalles 569
Santa Clara 561
Council Bluffs 540
New York 524
Los Angeles 439
Tokyo 369
Ho Chi Minh City 361
Lawrence 348
Dallas 292
Hanoi 279
Lauterbourg 263
Zhengzhou 257
Moscow 252
Buffalo 243
San Diego 226
Menlo Park 200
Milan 199
Boardman 179
Munich 178
Kraków 162
São Paulo 161
Helsinki 147
Chicago 132
London 127
Orem 117
Redwood City 109
Montreal 104
Nuremberg 104
Redondo Beach 95
Toronto 93
Shanghai 91
Warsaw 87
Seoul 85
Chennai 82
Lappeenranta 82
Jakarta 81
Atlanta 80
Frankfurt am Main 76
Mülheim 74
Brooklyn 69
Cedarhurst 65
Denver 65
Amsterdam 63
North Bergen 63
Norwalk 62
Guangzhou 57
Brussels 55
Haiphong 52
Nanjing 52
Rio de Janeiro 50
Hefei 49
Johannesburg 48
Salt Lake City 48
Stockholm 48
Manchester 47
Boston 46
Da Nang 46
Phoenix 45
Belo Horizonte 43
Naples 43
Colorado Springs 42
San Francisco 42
Falls Church 40
San Mateo 40
Engelhard 38
Paris 38
Elk Grove Village 36
Vienna 36
Florence 35
Mexico City 33
Verona 33
Columbus 31
Detroit 31
Mountain View 31
Mumbai 31
Nanchang 31
Poplar 31
Esslingen am Neckar 30
Porto Alegre 29
Dhaka 28
Baghdad 27
Bologna 27
Totale 94.815
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.639
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.396
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.218
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 760
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 757
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 695
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 621
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 577
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 555
Efficacy and safety of infliximab in psoriatic patients over the age of 65 545
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 531
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 528
Leflunomide-induced DRESS syndrome 528
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 508
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 499
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 493
Topical lactoferrin can improve stable psoriatic plaque 492
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 489
Angiosarcoma cutaneo epitelioide 484
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 484
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 482
Apremilast for the treatment of psoriasis. 476
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 466
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 465
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 464
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 464
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 463
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 461
Cheratodermia puntata porocheratosica 460
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 459
Treatment of trachyonychia with tazarotene 457
Actinic keratosis treated with an immune response modifier: a case report of six patients 456
Tazarotene as alternative topical treatment for onychomycosis 455
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 453
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 452
Psodisk, a new visual method for assessing the burden of psoriasis on patients 451
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 449
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 445
Treatment of kerion with fluconazole [30] 443
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 443
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 441
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 440
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 440
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 439
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 436
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 436
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 433
Brodalumab for the treatment of psoriasis 433
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 433
Phrynoderma: a cutaneous sign of an inadequate diet 431
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 430
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 426
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 425
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 424
Tildrakizumab for treating psoriasis 423
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 422
Stress reactivity in psoriatic patients 422
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 421
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 419
Severe acne successfully treated with etanercept 419
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 418
Non-familial porphyria cutanea tarda: a case report of a rare disease 418
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 417
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 417
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 416
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 411
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 411
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 411
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 410
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 410
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 407
Quality-of-life impairment in hidradenitis suppurativa 407
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 406
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 406
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 405
Confocal reflectance microscopy in pityriasis rubra pilaris 403
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 403
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 403
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 403
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 401
Erysipeloid cutaneous metastasis from bladder carcinoma 400
Elementi di dermatologia 400
Psoriasiform sarcoidosis: an unusual variety 399
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 397
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 397
Tofacitinib for the treatment of psoriasis 397
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 397
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 396
Mixoma intramuscolare del volto 394
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 394
Expression and potential role of cellular retinol binding protein I in psoriasis 394
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. 392
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 392
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 391
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 391
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 390
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 390
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 389
Blood MUC-18/MCAM expression in patients with melanoma: A suitable marker of poor outcome 388
Totale 47.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 310.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 310.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021774 0 0 0 0 0 0 0 0 0 0 497 277
2021/20223.947 203 434 264 176 177 306 311 188 263 311 285 1.029
2022/20235.061 489 586 198 612 457 1.114 422 285 465 75 233 125
2023/20242.280 247 69 139 72 183 424 225 183 53 192 93 400
2024/202512.269 332 2.051 1.128 654 250 852 809 560 1.032 967 2.061 1.573
2025/202617.426 1.481 810 2.156 1.558 1.645 698 2.517 2.245 2.393 1.891 32 0
Totale 119.124